<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport Reports Record Results; Grows Revenue by 50% for the First Nine Months of Fiscal 2015

February 5, 2015

LAKE FOREST, CA – February 5, 2015 — Cryoport, Inc. (CYRX) today announced financial results for its fiscal third quarter and nine months ended December 31, 2014.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, Frozen, Life Sciences, CYRX 3Q FY15 Earnings Release

Cryoport to Report Financial Results for Fiscal Third Quarter of 2015 and Provide Business Update on Thursday, February 5th

January 29, 2015

Lake Forest, CA, January 29, 2015 - Cryoport, Inc. (OTCBB:CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it will release its financial results for the fiscal third quarter ended December 31, 2014 on Thursday, February 5th.  

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, shipping solution, Frozen, sales force, Life Sciences

Cryoport Expands Sales Force To Address Growing Life Sciences Industry Demand

January 26, 2015

Lake Forest, CA, January 26, 2015 - Cryoport, Inc. (OTCBB: CYRX) (“Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced the expansion and restructuring of its national sales force in the United States.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, shipping solution, Frozen, sales force, Life Sciences

Cryoport Appoints Mark W. Sawicki as Chief Commercial Officer to Lead Sales and Marketing Team

January 20, 2015

Lake Forest, CA, January 20, 2015 - Cryoport, Inc. (OTCBB: CYRX) ( “Company”), the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced the appointment of Mark W. Sawicki, Ph.D. as Chief Commercial Officer of Cryoport Systems.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, board, shipping solution, Frozen

Cryoport Appoints Richard J. Berman to its Board of Directors

January 12, 2015

Lake Forest, CA, January 12, 2015 - Cryoport, Inc. (OTC BB:CYRX) (“Company”), the leading provider of advanced  cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, contract research organizations , vaccine manufacturers, and IVF, today announced the appointment of Richard J. Berman to its Board of Directors. Mr. Berman will also serve as Chairman of the Audit Committee and Compensation Committee.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, board, shipping solution, Frozen, Richard J. Berman

Cryoport Designated as Exclusive Cryogenic Logistics Provider to Triangle Research Labs

December 29, 2014

Lake Forest, CA, December 29, 2014 - Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for life sciences, announced today that it has entered into an agreement with Triangle Research Labs, LLC (“TRL”).  Under the agreement, Cryoport becomes the exclusive cryogenic logistics provider for TRL, providing it with the ability to support its overall demand growth and meet its ever-increasing demand for same day cryogenic shipping.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Triangle Research Labs, hepatocyte

Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015

November 12, 2014

LAKE FOREST, CA – November 12, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Revenue, fiscal 2015

Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry

November 3, 2014

Lake Forest, CA, November 3, 2014 - Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry.

Read More


Tags: Press Releases, News, Dry Shipper, Frozen Shipping, Frozen Shipping, frozen shipping solution, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, UPS

Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists

October 14, 2014

Lake Forest, CA (October 14, 2014) - Cryoport, Inc. (OTC:CYRX) announced today the first phase of deploying its “Regenerative Medicine Point-of-Care Repository Solution” for Liventa Bioscience’s introduction of Liventa’s AmnioClear® LCT therapy to orthopedic clinics in the US. More than 70 orthopedic clinics have expressed interest in the therapy. Of these clinics, approximately 20 have entered into a registry/ clinical study with Liventa.  

Read More


Tags: Dry Shipper, Frozen Shipping, Cold Chain Logistics, cold shipping, Liventa, Regenerative Medicine Point-of-Care Repository Sol, AmnioClear®

Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe

September 16, 2014

LAKE FOREST, CA – September 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the world’s leading provider of advanced cryogenic logistics solutions for the life-sciences industry, announced today that it has engaged Broekman Group, a global logistics company headquartered in Rotterdam, the Netherlands, to provide support to their rapidly expanding European client base. According to the terms of the agreement, Broekman’s European operations will support Cryoport’s leading-edge cryogenic logistics solutions throughout Europe.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Europe, Broekman Group